FunPep Company Limited Logo

FunPep Company Limited

Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.

4881 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
茨木市彩都あさぎ七丁目7−15
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

FunPep Company Limited is a clinical-stage biotechnology company that originated as a spin-out from Osaka University. The company specializes in the research and development of therapeutics based on its proprietary functional peptide and antibody-inducing peptide platform technologies. Its core business is creating novel peptide-based pharmaceutical products. FunPep's development pipeline includes candidates for various indications, such as an allergy vaccine and the functional peptide SR-0379 for intractable ulcers, which has advanced to late-stage clinical trials. The company's business scope also extends to the development of functional cosmetics and medical devices, leveraging the diverse applications of its core peptide technology.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for FunPep Company Limited and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 08:30
Regulatory News Service
確認書
Japanese 8.4 KB
2025-08-14 08:30
Interim Report
半期報告書-第13期(2025/01/01-2025/12/31)
Japanese 278.9 KB
2025-04-01 08:30
Regulatory News Service
臨時報告書
Japanese 23.2 KB
2025-03-28 08:16
Regulatory News Service
確認書
Japanese 8.5 KB
2025-03-28 08:15
Annual Report
有価証券報告書-第12期(2024/01/01-2024/12/31)
Japanese 1.6 MB
2025-03-28 08:15
Regulatory News Service
内部統制報告書-第12期(2024/01/01-2024/12/31)
Japanese 23.6 KB
2025-02-21 07:30
Prospectus
有価証券届出書(組込方式)
Japanese 447.3 KB
2024-08-08 09:01
Regulatory News Service
確認書
Japanese 8.4 KB
2024-08-08 09:00
Interim Report
半期報告書-第12期(2024/01/01-2024/12/31)
Japanese 283.1 KB
2024-08-08 03:00
Regulatory News Service
臨時報告書
Japanese 21.3 KB
2024-07-05 08:05
Prospectus
有価証券届出書(組込方式)
Japanese 391.3 KB
2024-05-13 08:00
Regulatory News Service
確認書
Japanese 8.4 KB
2024-05-13 08:00
Quarterly Report
四半期報告書-第12期第1四半期(2024/01/01-2024/03/31)
Japanese 238.2 KB
2024-04-01 08:05
Regulatory News Service
臨時報告書
Japanese 27.7 KB
2024-03-28 07:15
Regulatory News Service
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all FunPep Company Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for FunPep Company Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.